Stem cells: the blue print for the future.
The investment going into stem-cell therapies and technologies is impressive. The objectives are great, including the aim of tissues on demand within 20 years, and the rewards potentially huge with a suggested annual market of US dollar 500 billion. This article outlines current activities on both sides of the Atlantic.